Lymphoma, Large Cell Completed Phase 1 / 2 Trials for Veltuzumab (DB05656)

Also known as: Large Cell Lymphoma / Lymphoma, Large-Cell / Large-cell Lymphoma

IndicationStatusPhase
DBCOND0032452 (Lymphoma, Large Cell)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00546793Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLLTreatment